Oxaliplatin versus Mitomycin C following complete cytoreduction for colorectal peritoneal metastases: a comparative study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-019-04447-y
Abstract: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) can offer selected patients with colorectal peritoneal metastases (CRPM) a favorable long-term survival. While cytoreductive techniques are standardized, there remains great variability in HIPEC drugs with mitomycin… read more here.
Keywords: complete cytoreduction; colorectal peritoneal; peritoneal metastases; mitomycin ... See more keywords
Tumor Load Matters – the Peritoneal Cancer Index in Patients With High-grade Serous Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15987
Abstract: Abstract Background/Aim: The aim of this study was to analyze the predictive and prognostic value of the peritoneal cancer index (PCI) with regard to complete cytoreduction and clinical outcomes in patients with high-grade serous ovarian… read more here.
Keywords: cytoreduction; high grade; patients high; complete cytoreduction ... See more keywords
Predicting incomplete cytoreduction in patients with advanced ovarian cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1060006
Abstract: Purpose The most important prognostic factor for survival in ovarian cancer patients is complete cytoreduction. The preoperative prediction of suboptimal cytoreduction, considered as any residual disease at the end of surgery, could prevent futile surgery… read more here.
Keywords: cytoreduction; residual disease; ovarian cancer; incomplete cytoreduction ... See more keywords